New Comprehensive Data Platform Accelerates Application Development and Deployment

InterSystemsInterSystems, a global leader in information technology platforms for health, business, and government applications, has introduced the InterSystems IRIS Data Platform®. Built around a high-performance database, InterSystems IRIS is the first and only data platform to provide all of the critical capabilities for rapidly developing data-intensive and mission- critical applications, including advanced data management, interoperability, transaction processing, and analytics.

The platform includes:

  • An advanced multi-model, multi-workload data management engine;
  • Native interoperability;
  • An open analytics platform;
  • Easy deployment in cloud, on-premises or hybrid environments;
  • A unique combination of horizontal and vertical scalability, enabling systems to scale up and down to accommodate rapidly changing workloads and data volumes; and
  • World-class 24/7 customer support

The development and naming of the InterSystems IRIS Data Platform is based on the company's foundational design principles. IRIS stands for Interoperable, Reliable, Intuitive and Scalable - four attributes that InterSystems and its customers believe are required to capitalise on the growing volumes of data entering organisations every day.

According to a recent IDC InfoBrief, commissioned by InterSystems, entitled "Choosing a DBMS to Address the Challenges of the Third Platform," 47 percent of organisations report that untimely data has negatively impacted their business. One of the biggest drivers of untimely data is the reliance on extract, transform, and load (ETL) infrastructures to move data between applications and platforms. By simultaneously performing transactions and analytics in one unified platform, InterSystems IRIS eliminates the need for ETL and provides immediate insights and actions based on the most current data. With native interoperability, the platform integrates seamlessly with existing architectures, systems, and devices accelerating the development and delivery of data-driven applications.

"We created InterSystems IRIS Data Platform with solution creators in mind with all of the critical capabilities for building applications that face the future," said Paul Grabscheid, vice president of Strategic Planning, InterSystems. "The introduction of the IRIS Data Platform represents a significant step forward in the database industry and builds on InterSystems' rich history of technical innovations focused on solving real business problems."

IRIS is the newest member of the InterSystems data platform product family, which also includes the Caché high-performance multi-model database and Ensemble application integration engine. Most customers will be able to upgrade to IRIS Data Platform easily - and for free - should they want to do so.

"Increasingly, enterprises want to be able to perform analytics and transactions on a coherent set of current data, rather than having a specialised, separate database for each operational and analytical workload," said Carl Olofson, research vice president of Data Management Software at IDC.

"InterSystems is leveraging its open architecture to deliver the IRIS Data Platform, which is designed to integrate seamlessly into existing infrastructures and apply best-of-breed technologies to support the widest range of customer environments and application requirements."

The InterSystems IRIS Data Platform will be available worldwide in January 2018.

About InterSystems
InterSystems is the engine behind the world's most important applications. In healthcare, finance, government, and other sectors where lives and livelihoods are at stake, InterSystems is the power behind what mattersTM. Founded in 1978, InterSystems is a privately held company headquartered in Cambridge, Massachusetts (USA), with offices worldwide, and its software products are used daily by millions of people in more than 100 countries.

Most Popular Now

Researchers Capture First Images of Oxyg…

Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful. Hypoxia, or starvation of oxygen, in solid tumors is also thought to be...

VTT Makes New Investments in Digital Hea…

VTT is launching new research activities in the area of digital health as part of the growing wellbeing and health technology ecosystem in Kuopio. The new initiative aims to create...

A New Method of Artificial Intelligence …

Despite the immense progress in the field of AI in recent years, we are still very far from human intelligence. Indeed, if current AI techniques allow to train computer agents...

FDA Informs Health Care Providers, Facil…

Today, the U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central...

eHealthWeek 2020 Croatia - Trusted Infor…

15 - 17 April 2020, Rovinj, Croatia. In its capacity of hosting the upcoming Presidency of the Council of the European Union, the Croatian Ministry of Health is in preparations to...

NHS IT Chiefs Set the Stage for a Year o…

3 - 4 March 2019, London, United Kingdom. NHS technology leaders are to kick off the second-ever Digital Health Rewired Conference and Exhibition on 3 - 4 March at the Olympia...

Siemens Healthineers Presents Solutions …

CT scanners with intelligent user guidance, AI-based software assistants for MRI and a lab system that revolutionizes workflows: Siemens Healthineers is showcasing its products and solutions according to the motto...

PatchAi Startup has Arrived in the Marke…

PatchAi - a startup that offers, thanks to Artificial Intelligence and Machine Learning, an empathic virtual assistant to patients participating in clinical trials - announced that it has closed two...

Digital Health App Medicus AI Earns CE C…

Medicus AI, the Vienna-based health tech company, has received a ​Class I Medical Device CE Mark for its mobile application. The CE certification mark confirms that Medicus AI conforms to...

FDA Authorizes Marketing of First Cardia…

Today, the U.S. Food and Drug Administration authorized marketing of software to assist medical professionals in the acquisition of cardiac ultrasound, or echocardiography, images. The software, called Caption Guidance, is...

Human Body-on-Chip Platform Enables In V…

Drug development is an extremely arduous and costly process, and failure rates in clinical trials that test new drugs for their safety and efficacy in humans remain very high. According...

AI in Drug Discovery Conference 2020

16 - 17 March 2020, London, UK. SMi group presents the launch of the inaugural AI in Drug Discovery conference taking place in London. AI-empowered machine learning technologies hold the potential...